AbbVie’s migraine drug Atogepant just cleared a major Phase 3 hurdle, and it’s got Wall Street rubbing its temples—in ...

Robert F. Kennedy Jr.’s plan for America’s vaccines is coming into focus, with his revamped immunization advisory panel set ...

Aluminum-containing adjuvants are ingredients that have been used in vaccines since the 1930s, according to the U.S. Centers ...

The Health and Human Services secretary Robert F. Kennedy Jr's new vaccine advisory panel will discuss and vote on the use of ...

The market is projected to surge from $2.52 billion in 2024 to $2.95 billion in 2025 at a compound annual growth rate CAGR of 17.1%. What Are The Projections For The Future Growth Of The Liver Cancer ...

AbbVie just scored an FDA win as its antiviral drug Mavyret received label expansion to treat acute Hepatitis C. The FDA ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Keytruda marks the first perioperative anti-PD-1 treatment option for adults with PD-L1–positive resectable locally advanced ...

Global Oral Antiviral Market is valued approximately USD 36.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 2.10% over the forecast period 2024-2032. Read the ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is undergoing a significant transformation in its therapeutic and competitive landscape. Accounting for approximately 75% ...